Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Cancer Research

• Publication date

  1983-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 6861130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent advances in cancer cytogenetics.

  1981cited by this paper
• Recent advances in cancer cytogenetics.

  1981cited by this paper
• High-affinity anti-oestrogen binding site distinct from the oestrogen receptor

  1980cited by this paper
• Epidermal growth factor stimulation of human breast cancer cells in culture.

  1980cited by this paper
• Effects of estrogen and antiestrogen on DNA polymerase in human breast cancer.

  1980cited by this paper
• Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing.

  1978cited by this paper
• Mapping G1 phase by the structural morphology of the prematurely condensed chromosomes

  1978influential reference
• Antiestrogens: Mechanism of Action and Effects in Breast Cancer

  1978cited by this paper
• Flow microfluorimetric analysis of sensitive and resistant leukemia L1210 following 1-beta-D-arabinofuranosylcytosine in vivo.

  1976cited by this paper
• The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.

  1976cited by this paper
• Antiestrogenic and antitumor properties of tamoxifen in laboratory animals.

  1976cited by this paper
• Interactions of antiestrogens with human breast cancer in long-term tissue culture.

  1976cited by this paper
• MATHEMATICAL ANALYSIS OF DNA DISTRIBUTIONS DERIVED FROM FLOW MICROFLUOROMETRY

  1974influential reference
• In vitro determination of thymidine-3H labeling index in human solid tumors.

  1974cited by this paper
• Recent advances in cancer.

  1952cited by this paper
• For April.

  1903cited by this paper
• August

  1890cited by this paper

• miRNA-dependent resistance mechanisms to anti-hormonal therapies in estrogen receptor-positive breast cancer patients

  2025cites this paper
• Guidelines about radiotherapy and oncologic systemic treatments: Stop or continue?

  2025cites this paper
• Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition

  2024cites this paper
• Prolonged tamoxifen‐enriched diet is associated with cardiomyopathy and nutritional frailty in mice

  2024cites this paper
• Targeted Therapies and Drug Resistance in Advanced Breast Cancer, Alternative Strategies and the Way beyond

  2024cites this paper
• The anti-aromatase and anti-estrogenic activity of plant products in the treatment of estrogen receptor-positive breast cancer.

  2024cites this paper
• Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells

  2023cites this paper
• Effects of 7-ketocholesterol on tamoxifen efficacy in breast carcinoma cell line models in vitro.

  2023cites this paper
• N-(benzazol-2-yl)-2-substituted phenylacetamide derivatives: design, synthesis and biological evaluation against MCF7 breast cancer cell line

  2023cites this paper
• Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions

  2022cites this paper
• Combinatorial treatments of tamoxifen and SM6Met, an extract from Cyclopia subternata Vogel, are superior to either treatment alone in MCF-7 cells

  2022cites this paper
• Concurrent Radiation and Modern Systemic Therapies for Breast Cancer: An Ever-Expanding Frontier.

  2021cites this paper
• In silico simulation of the effect of hypoxia on MCF-7 cell cycle kinetics under fractionated radiotherapy

  2021influential citation
• Knockdown of vps54 aggravates tamoxifen-induced cytotoxicity in fission yeast

  2021cites this paper
• Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies

  2021cites this paper
• MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit

  2021cites this paper
• Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer

  2021influential citation
• Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team

  2021cites this paper
• Evaluation of the In Vitro and In Vivo Antitumor Efficacy of Peanut Sprout Extracts Cultivated with Fermented Sawdust Medium Against Bladder Cancer

  2020cites this paper
• Anti-Estrogenic Activity of Guajadial Fraction, from Guava Leaves (Psidium guajava L.)

  2020cites this paper
• Hormone Therapy Models

  2020cites this paper
• Changes in DNA damage repair gene expression and cell cycle gene expression do not explain radioresistance in tamoxifen-resistant breast cancer.

  2020cites this paper
• In Vitro and In Vivo Antitumor Efficacy of Hizikia fusiforme Celluclast Extract against Bladder Cancer

  2020cites this paper
• Pathological Evaluation of Anti-tumour Effects Withaferin A against Experimentally Induced Mammary Tumour in Rats

  2020cites this paper
• Carnosine exerts antitumor activity against bladder cancers in vitro and in vivo via suppression of angiogenesis.

  2019cites this paper
• INVESTIGATING THE EFFECT OF DIFFERENT ANIMAL VENOMS ON BREAST CANCER CELL LINES (MCF-7): IN VITRO STUDY

  2019cites this paper
• Mechanisms of cross-resistance to radiotherapy and tamoxifen treatment in breast cancer

  2019cites this paper
• Targeting Apoptosis: A New Paradigm for the Treatment of Estrogen Receptor-Positive Breast Cancer.

  2019cites this paper
• Endocrine Therapy for Hormone Receptor‐Positive Breast Cancer

  2019cites this paper
• Long Noncoding RNA Signature and Disease Outcome in Estrogen Receptor-Positive Breast Cancer Patients Treated with Tamoxifen

  2018cites this paper
• Tamoxifen-Induced Apoptosis of MCF-7 Cells via GPR30/PI3K/MAPKs Interactions: Verification by ODE Modeling and RNA Sequencing

  2018cites this paper
• Endocrine Therapy of Metastatic Breast Cancer

  2018cites this paper
• Hydrangenol inhibits the proliferation, migration, and invasion of EJ bladder cancer cells via p21WAF1-mediated G1-phase cell cycle arrest, p38 MAPK activation, and reduction in Sp-1-induced MMP-9 expression

  2018cites this paper
• EFFECT OF PACLITAXEL, EPIRUBICIN AND TAMOXIFEN

  2018cites this paper
• Nano Packaged Tamoxifen and Curcumin; Effective Formulation against Sensitive and Resistant MCF-7 Cells

  2018cites this paper
• Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial

  2018cites this paper
• Ethanol extract of loquat fruit skin inhibits the proliferation and metastatic potential of EJ human bladder carcinoma cells

  2017cites this paper
• Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers

  2017cites this paper
• The use of concurrent hormonotherapy and radiotherapy does not deteriorate radiation-induced cardiac toxicity

  2017cites this paper
• Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.

  2017cites this paper
• Opportunities and challenges of long term anti-estrogenic adjuvant therapy: treatment forever or intermittently?

  2017cites this paper
• The long range regulation of breast cancer associated genes

  2016cites this paper
• The phytoestrogenic Cyclopia extract, SM6Met, increases median tumor free survival and reduces tumor mass and volume in chemically induced rat mammary gland carcinogenesis.

  2016cites this paper
• Rationalizing Optimal Timing for Adjuvant Hormone Therapy for Patients with Breast Cancer: Impact on Limited Resource Countries

  2016cites this paper
• Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.

  2016cites this paper
• Treatment of Metastatic Breast Cancer: Endocrine Therapy

  2016cites this paper
• GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells.

  2016cites this paper
• Determination of the optimal time for tamoxifen treatment in combination with radiotherapy.

  2016cites this paper
• Selective estrogen receptor modulators in clinical practice: a safety overview

  2015cites this paper
• MCF-7 cells--changing the course of breast cancer research and care for 45 years.

  2015influential citation
• Modulation of Tamoxifen Cytotoxicity by Caffeic Acid Phenethyl Ester in MCF-7 Breast Cancer Cells

  2015cites this paper
• In vitro effects of tamoxifen on adipose‐derived stem cells

  2015cites this paper
• Regulation of T-Type Ca2+ Channels in Cancer Cell Cycle

  2015cites this paper
• T-type Calcium Channels in Basic and Clinical Science

  2015cites this paper
• E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter

  2015cites this paper
• Chapter 2 Tamoxifen Goes Forward Alone

  2015cites this paper
• The influence of tamoxifen on normal mouse mammary gland homeostasis

  2014cites this paper
• Interactions of Endoxifen and other major metabolites of Tamoxifen with human sulfotransferases SULT2A1, SULT1E1, and SULT1A1*1 : implications for the therapeutic action and toxicity of Tamoxifen

  2014cites this paper
• Phytoestrogenic extracts of Cyclopia modulate molecular targets involved in the prevention and treatment of breast cancer

  2014cites this paper
• [Breast cancer: radiotherapy and estrogen signaling].

  2014cites this paper
• Nordamnacanthal potentiates the cytotoxic effects of tamoxifen in human breast cancer cells

  2014cites this paper
• Genetics and epigenetics of direct and indirect radiation responses in normal mammary and breast cancer cells

  2014cites this paper
• Synergy of novel coumarin derivatives and tamoxifen in blocking growth and inducing apoptosis of breast cancer cells

  2014cites this paper
• Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cells

  2014cites this paper
• Endocrine Therapy for Breast Cancer

  2014cites this paper
• Cancer du sein : radiothérapie et signalisation œstrogénique

  2014cites this paper
• Altered radiation responses of breast cancer cells resistant to hormonal therapy

  2014cites this paper
• erapie dans le cancer du sein et l'observance des traitements : quel est le r^ ole du pharmacien ocinal ?

  2013cites this paper
• ' s response to reviews Title : Promoting E 2 F 1-mediated apoptosis in oestrogen receptor-alpha-negative breast cancer cells

  2013cites this paper
• Nuclear estrogen receptors co-activation mechanisms.

  2013cites this paper
• Tamoxifen Goes Forward Alone

  2013cites this paper
• Management Of Metastatic Breast Cancer (MBC).

  2013cites this paper
• Comparison of the effects of aromatase inhibitors and tamoxifen on radiation-induced lung toxicity: results of an experimental study

  2013cites this paper
• The Role of Redox Signaling in the Molecular Mechanism of Tamoxifen Resistance in Breast Cancer

  2012cites this paper
• Activation of estrogen receptor-alpha by nitrite

  2012cites this paper
• L'hormonothérapie dans le cancer du sein et l'observance des traitements : quel est le rôle du pharmacien officinal ?

  2012cites this paper
• Tamoxifen-loaded thiolated alginate-albumin nanoparticles as antitumoral drug delivery systems.

  2012cites this paper
• High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

  2012cites this paper
• Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: comparison with tamoxifen

  2012cites this paper
• Tamoxifen and its new derivatives in cancer research.

  2011cites this paper
• Mechanisms of V600EBRAF-induced tumour development

  2011cites this paper
• Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo

  2011cites this paper
• High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

  2011cites this paper
• An investigation into the effects of the epidermal growth factor receptor tyrosine kinase inhibitor "Gefitinib" on human breast cancer

  2010cites this paper
• Cell Cycle and Anti-Estrogen Effects Synergize to Regulate Cell Proliferation and ER Target Gene Expression

  2010cites this paper
• Antagonistic interaction between bicalutamide™ (Casodex®) and radiation in androgen‐positive prostate cancer LNCaP cells

  2010cites this paper
• Biomarkers of Radiosensitivity in A-Bomb Survivors Pregnant at the Time of Bombings in Hiroshima and Nagasaki

  2010cites this paper
• Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations

  2010cites this paper
• Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale?

  2009cites this paper
• Combining systemic therapies with radiation in breast cancer.

  2009cites this paper
• AntagonisticInteractionBetweenBicalutamide TM (Casodex 1 )andRadiationinAndrogen-Positive ProstateCancerLNCaPCells

  2009cites this paper
• Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells

  2009cites this paper
• Role of the pharmaceutical excipients in the tamoxifen activity on MCF-7 and vero cell cultures.

  2009cites this paper
• Meningioma estrogen-and progesterone-binding protein levels and binding affinity ( Kd ) values Estrogen Binding Progesterone

  2009cites this paper
• Estrogen receptor expression in adrenocortical carcinoma

  2009cites this paper
• CHAPERONE EXPRESSION AND EFFECTS OF ITS INHIBITION ON BREAST CANCER SENSITIZATION

  2009cites this paper
• [Adjuvant breast cancer treatment with hormono-radiotherapy].

  2009cites this paper
• Tamoxifen-2-hydroxylpropyl-beta-cyclodextrin-aggregated nanoassembly for nonbreast estrogen-receptor-positive cancer therapy.

  2009cites this paper
• The nuclear factor kappa b (NFkb) plays a critical role in the development of antiestrogen resistance

  2009cites this paper
• Differential protein expression analysis using stable isotope labeling and PQD linear ion trap MS technology

  2009cites this paper